


Searching News Database: CORD I
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 26 Nov 2025
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
Restore Medical Appoints Former Medtronic Executive Chris Cleary as Chairman of the Board
HSMN NewsFeed - 19 Nov 2025
CMS Establishes National Pricing for Vesiflo's inFlow(TM) Voiding Prosthesis
CMS Establishes National Pricing for Vesiflo's inFlow(TM) Voiding Prosthesis
HSMN NewsFeed - 16 Oct 2024
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
HSMN NewsFeed - 10 Sep 2024
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
Affinia Therapeutics Announces the Appointment of Rami Daoud as Chief Business and Financial Officer
HSMN NewsFeed - 29 Aug 2024
Expanse Medical Welcomes Jeff Hopkins as CEO and Board Member of its Spin-Off, FlowPhysix
Expanse Medical Welcomes Jeff Hopkins as CEO and Board Member of its Spin-Off, FlowPhysix
HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
HSMN NewsFeed - 23 May 2024
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
SystImmune, Inc. Announces the Appointment of Dr. Jonathan Cheng as New Chief Medical Officer
HSMN NewsFeed - 2 May 2024
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed - 29 Mar 2024
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
RIVANNA(R) Appoints Craig Loomis as Senior Director of Product Management
HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
HSMN NewsFeed - 25 Jul 2022
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
HSMN NewsFeed - 27 May 2022
Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio
Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio
HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
HSMN NewsFeed - 28 Oct 2021
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer
HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
HSMN NewsFeed - 13 Sep 2021
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 5 Jul 2021
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
HSMN NewsFeed - 9 Jun 2021
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
HSMN NewsFeed - 1 Jul 2020
Hallura Announces the Appointment of Paul Navarre to Its Board of Directors
Hallura Announces the Appointment of Paul Navarre to Its Board of Directors
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 23 Jan 2020
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
HSMN NewsFeed - 12 Sep 2019
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
HSMN NewsFeed - 16 Aug 2019
Zimmer Biomet's Innovative Treatment for Young Patients with Scoliosis Receives FDA Approval
Zimmer Biomet's Innovative Treatment for Young Patients with Scoliosis Receives FDA Approval
HSMN NewsFeed - 22 Jul 2019
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
HSMN NewsFeed - 18 Mar 2019
Via Surgical Receives FDA Clearance for Its FasTouch(TM) Absorbable Fixation System
Via Surgical Receives FDA Clearance for Its FasTouch(TM) Absorbable Fixation System
HSMN NewsFeed - 19 Feb 2019
ReWalk Announces 510k FDA Submission for ReStore(TM) Exo-Suit for Stroke Rehabilitation
ReWalk Announces 510k FDA Submission for ReStore(TM) Exo-Suit for Stroke Rehabilitation
HSMN NewsFeed - 11 Feb 2019
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
HSMN NewsFeed - 31 Oct 2018
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
HSMN NewsFeed - 24 Sep 2018
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
HSMN NewsFeed - 11 Sep 2018
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
HSMN NewsFeed - 27 Jul 2018
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
Accord Healthcare’s (Intas) Pelgraz(R) (pegfilgrastim) Given Green Light by CHMP
HSMN NewsFeed - 11 Jun 2018
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
HSMN NewsFeed - 26 Apr 2018
Vyaire Medical executes on its plan to become a global leader in respiratory care
Vyaire Medical executes on its plan to become a global leader in respiratory care
HSMN NewsFeed - 25 Apr 2018
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
HSMN NewsFeed - 17 Jan 2018
Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey
Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 30 Jun 2017
Xiapex(R) Gets Recommendation to be Made Available on National Health Service in England
Xiapex(R) Gets Recommendation to be Made Available on National Health Service in England
HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
HSMN NewsFeed - 3 Apr 2017
MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer
MEI Pharma Announces Appointment of Brian Drazba as Chief Financial Officer
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 25 Jan 2017
Vioguard Secures $5MM Series A Financing Round Led by Imagen Capital Partners
Vioguard Secures $5MM Series A Financing Round Led by Imagen Capital Partners
HSMN NewsFeed - 17 Jan 2017
Launch of New Spectrum Single-Use Blades Marks The Latest Advance from GlideScope Video Laryngoscopes
Launch of New Spectrum Single-Use Blades Marks The Latest Advance from GlideScope Video Laryngoscopes
HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
HSMN NewsFeed - 12 Sep 2016
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
HSMN NewsFeed - 18 Aug 2016
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
HSMN NewsFeed - 4 Aug 2016
Inspyr Therapeutics Appoints Christopher Lowe Chief Executive Officer and Director
Inspyr Therapeutics Appoints Christopher Lowe Chief Executive Officer and Director
HSMN NewsFeed - 20 Jul 2016
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 4 Apr 2016
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
HSMN NewsFeed - 8 Mar 2016
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
Medgenics Hires Rick Couch, Ph.D. to Vice President of Chemistry, Manufacturing and Controls
HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 25 Jan 2016
Vertice Pharma appoints Dr. Indranil Nandi as Vice President, Research & Development
Vertice Pharma appoints Dr. Indranil Nandi as Vice President, Research & Development
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 15 Sep 2015
Makindus Bolsters Management Team with Appointment of Michael Celano as Chief Financial Officer
Makindus Bolsters Management Team with Appointment of Michael Celano as Chief Financial Officer
HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
HSMN NewsFeed - 1 Jul 2015
Spine Wave Announces the Commercial Launch of the Leva(TM) Interbody Device System
Spine Wave Announces the Commercial Launch of the Leva(TM) Interbody Device System
HSMN NewsFeed - 9 Jun 2015
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development
HSMN NewsFeed - 28 May 2015
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
HSMN NewsFeed - 18 May 2015
Vesiflo Introduces the inFlow Device and Its Companion Patient Monitoring System
Vesiflo Introduces the inFlow Device and Its Companion Patient Monitoring System
HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
HSMN NewsFeed - 1 Apr 2015
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold
HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
HSMN NewsFeed - 4 Mar 2015
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
HSMN NewsFeed - 10 Dec 2014
Gore Receives CE Mark Approval for GORE(R) VIABAHN(R) Endoprosthesis for Revision of Arteriovenous Access
Gore Receives CE Mark Approval for GORE(R) VIABAHN(R) Endoprosthesis for Revision of Arteriovenous Access
HSMN NewsFeed - 2 Dec 2014
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
HSMN NewsFeed - 5 Aug 2014
TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer
TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer
HSMN NewsFeed - 22 Jul 2014
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
HSMN NewsFeed - 9 Jun 2014
Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors
Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors
HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 24 Feb 2014
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
HSMN NewsFeed - 28 Jan 2014
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
Veteran Biotech Executive David Arkowitz Joins Spring Bank Pharmaceuticals' Board of Directors
HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
HSMN NewsFeed - 25 Jul 2013
Aqua Pharmaceuticals, LLC Welcomes Brett Fair as Vice President of Corporate Development
Aqua Pharmaceuticals, LLC Welcomes Brett Fair as Vice President of Corporate Development
HSMN NewsFeed - 20 Jun 2013
Orthofix Realigns Business Units to Support Future Growth Opportunities and Announces Leadership Changes
Orthofix Realigns Business Units to Support Future Growth Opportunities and Announces Leadership Changes
HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
HSMN NewsFeed - 4 Apr 2013
InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
HSMN NewsFeed - 28 Feb 2013
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
HSMN NewsFeed - 21 Dec 2012
Spectrum Pharmaceuticals Announces Achievement of Primary Endpoint in Belinostat Registrational Trial
Spectrum Pharmaceuticals Announces Achievement of Primary Endpoint in Belinostat Registrational Trial
HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
HSMN NewsFeed - 18 Dec 2012
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
HSMN NewsFeed - 14 Dec 2012
InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
HSMN NewsFeed - 13 Jul 2012
Hackensack University Medical Center At Pascack Valley Appoints Healthcare Veteran Chad Melton As New CEO
Hackensack University Medical Center At Pascack Valley Appoints Healthcare Veteran Chad Melton As New CEO
HSMN NewsFeed - 2 Jul 2012
AngioScore Files Patent Infringement Suit Against TriReme Medical and Quattro
AngioScore Files Patent Infringement Suit Against TriReme Medical and Quattro
HSMN NewsFeed - 27 Jun 2012
BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
HSMN NewsFeed - 21 Jun 2012
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
HSMN NewsFeed - 1 Jun 2012
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
HSMN NewsFeed - 15 May 2012
Jim Cunniff Named Senior Vice President, Leading Commercial Activities in the Americas for KCI
Jim Cunniff Named Senior Vice President, Leading Commercial Activities in the Americas for KCI
HSMN NewsFeed - 14 May 2012
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System
HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
HSMN NewsFeed - 23 Apr 2012
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
HSMN NewsFeed - 26 Mar 2012
BSD Medical Appoints Sam Maravich as Vice President of Sales and Marketing
BSD Medical Appoints Sam Maravich as Vice President of Sales and Marketing
HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
HSMN NewsFeed - 19 Mar 2012
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
HSMN NewsFeed - 23 Feb 2012
Ascendx Spine(TM) elects Magnus Persson, MD, PhD, to its board of directors
Ascendx Spine(TM) elects Magnus Persson, MD, PhD, to its board of directors
HSMN NewsFeed - 22 Feb 2012
Stryker’s 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development
Stryker’s 2010 Innovator of the Year Brian Hess Joins InVivo Therapeutics as Director of Product Development
HSMN NewsFeed - 19 Jan 2012
Astellas Pharma Europe Ltd. Appoints Mike Crooks to Head up its UK Operations
Astellas Pharma Europe Ltd. Appoints Mike Crooks to Head up its UK Operations
HSMN NewsFeed - 7 Dec 2011
HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO
HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO
HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 16 Nov 2011
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
HSMN NewsFeed - 3 Nov 2011
Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device
Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
HSMN NewsFeed - 11 Aug 2011
SonoSite Appoints Mehran Mehrtash, Vice President, General Manager of Asia Pacific and the Middle East
SonoSite Appoints Mehran Mehrtash, Vice President, General Manager of Asia Pacific and the Middle East
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 1 Jun 2011
Affymetrix Appoints Frank Witney, Ph.D., as President and Chief Executive Officer
Affymetrix Appoints Frank Witney, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 28 Apr 2011
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
HSMN NewsFeed - 25 Apr 2011
A.P. Pharma Announces Financing of Up to $4.5 Million and Names CEO and COO
A.P. Pharma Announces Financing of Up to $4.5 Million and Names CEO and COO
HSMN NewsFeed - 18 Apr 2011
Warner Chilcott Announces Plans to Restructure Western European Operations
Warner Chilcott Announces Plans to Restructure Western European Operations
HSMN NewsFeed - 6 Apr 2011
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
HSMN NewsFeed - 1 Apr 2011
AngioScore Launches New Longer AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
AngioScore Launches New Longer AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
HSMN NewsFeed - 19 Jan 2011
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs
HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
HSMN NewsFeed - 1 Dec 2010
SpectraScience Announces Appointment of Michael Oliver as President and Chief Executive Officer
SpectraScience Announces Appointment of Michael Oliver as President and Chief Executive Officer
HSMN NewsFeed - 1 Dec 2010
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
HSMN NewsFeed - 16 Nov 2010
IBA and ProCure Set Record on Development of Second Proton Therapy Center
IBA and ProCure Set Record on Development of Second Proton Therapy Center
HSMN NewsFeed - 2 Nov 2010
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
HSMN NewsFeed - 28 Sep 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
HSMN NewsFeed - 27 Sep 2010
Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
HSMN NewsFeed - 13 Sep 2010
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
HSMN NewsFeed - 21 Jul 2010
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
Radient Pharmaceuticals Announces Exclusive Distribution Agreement With AMDL Australia Pty Ltd.
HSMN NewsFeed - 12 Jul 2010
Mirada Medical Announces the Appointment of Karsten Damgaard-Iversen as Non-Executive Chairman
Mirada Medical Announces the Appointment of Karsten Damgaard-Iversen as Non-Executive Chairman
HSMN NewsFeed - 7 Jul 2010
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Additional items found! 365
Members Archive contains
365 additional stories matching:
CORD I
(Password required)
CORD I
(Password required)
